Table 2.

Adjusted mean BMD change at the hip and calcaneus by diabetes status.

Site of BMD Change	Prevalent DM			Incident DM			Non-DM
	Change (%/year)	95% CI	p*	Change (%/year)	95% CI	p**	Change (%/year)	95% CI
FEMORAL NECK
Adjusted for age and site	−0.96	−1.17, −0.77	<0.001	−0.90	−1.22, −0.59	0.009	−0.59	−0.66, −0.53
MV without weight changea	−0.86	−1.10, −0.63	<0.001	−0.79	−1.14, −0.44	0.06	−0.54	−0.62, −0.46
MV with weight changea	−0.79	−1.03, −0.57	<0.001	−0.69	−1.04, −0.36	0.18	−0.51	−0.59, −0.44
TOTAL HIP
Adjusted for age and site	−0.98	−1.15, −0.82	<0.001	−0.98	−1.22, −0.75	0.001	−0.70	−0.76, −0.65
MV without weight changea	−0.86	−1.06, −0.68	<0.001	−0.77	−1.03, −0.52	0.06	−0.59	−0.66, −0.53
MV with weight change	−0.75	−0.92, −0.58	<0.001	−0.61	−0.86, −0.38	0.51	−0.55	−0.61, −0.50
CALCANEUS
Adjusted for age and site	−1.64	−2.06, −1.25	0.005	−1.43	−2.64, −0.40	0.94	−1.40	−1.54, −1.27
MV without weight changeb	−1.29	−1.75, −0.86	0.06	−0.83	−2.13, 0.27	0.57	−1.08	−1.24, −0.93
MV with weight change	−1.19	−1.65, −0.76	0.14	−0.68	−1.96, 0.40	0.44	−1.04	−1.19, −0.88

*p-Value for differential rate of BMD loss for prevalent DM vs. non-DM.

**p-Value for differential rate of BMD loss for incident DM vs. non-DM.

^aAdjusted for baseline age, clinic site, baseline height, baseline weight, height change since 25 years since menopause, current vitamin D use, current calcium use, current estrogen use, current use of osteoporosis medications, current thiazide diuretic use, current grip strength, current walking speed, current inability to rise from chair without use of arms, and decreased light touch.

^bAdjusted for baseline age, clinic site, baseline weight, baseline height, height change since age 25, years since menopause, current vitamin D use, current estrogen use, current thiazide use, current grip strength, current walking speed, current inability to rise from chair without use of arms, and current walking for exercise.